Clinical Trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2019-03-25; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2020-07-08
Trial Details
NCT Number NCT03889899
Lead Sponsor Alpha Tau Medical LTD.
Conditions Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Enrollment 30 participants
Start Date 2020-10-21
Primary Completion 2026-06 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-02